Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Emis Group Plc    EMIS   GB00B61D1Y04

EMIS GROUP PLC (EMIS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Emis Group Plc : Smarter software to make GP prescribing safer

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/05/2012 | 07:41am CEST
Friday, 4 May 2012

Smarter software to make GP prescribing safer

A call from the General Medical Council (GMC) for smarter software to help GPs reduce prescribing errors has highlighted EMIS's position as an industry leader in decision support technology.

Many of the issues highlighted in the GMC-commissioned study are already covered by the EMIS Web integrated care system - including sophisticated prescribing alerts that don't overload the GP and direct electronic links with pharmacists, closing the prescribing loop.

GMC chair Professor Peter Rubin said GPs needed to invest in better technology following a GMC-commissioned study that revealed mistakes or omissions in one in 20 prescriptions. The GMC also called for GPs and pharmacists to work together more closely to reduce the risk of errors.

Complex decisions

Dr Shaun O'Hanlon, clinical and development director at EMIS said: "This important study has revealed just how complex prescribing decisions are, and as a former GP, I know that there are times when we need to balance one risk against another - this is often not evident when reviewing the prescription in isolation.

"However, the good news is that the smart software called for by the GMC is already being implemented - an increasing number of GPs and pharmacists using EMIS Web, our integrated record system, have the very latest tools to make prescribing safer.

Avoid 'alert fatigue'

"EMIS Web includes advanced decision support for prescribing, which flags up key drug safety alerts that make GPs stop and think, and even justify their decision, circumventing 'alert fatigue'.

"It also allows GPs to monitor and manage patients on drugs with a low therapeutic index such as Warfarin more safely. Our medication management tool informs GPs when the patient they are seeing or prescribing for is overdue for an INR check - the commonest serious issue mentioned in the report. Integration in EMIS Web of SMS alerting to the patient when monitoring is overdue is another way of improving safety - and involving patients in their own care." 

Linking GPs and pharmacists

He added: "Close links between GPs and local community pharmacists are of course vital to improve prescribing, and the Medicines Manager tool, developed jointly by EMIS and Rx Systems, allows them to communicate with each other electronically about patients' repeat medication and exchange information directly.

"GPs and community pharmacies are already collaborating when making complex prescribing decisions and are realising the benefits in terms of patient safety, compliance and improved care."

Media enquiries: Contact Libby Howard or Ruth Devlin, Judge & Howard,
tel: 0161 212 1611, email . Out-of-hours enquiries to
Libby Howard on 07879 446277.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EMIS GROUP PLC
03/29EMIS GROUP PLC : Ex-dividend day for final dividend
FA
03/09EMIS GROUP PLC : annual earnings release
2017EMIS : Egton migrates to UKCloud's award-winning Cloud Native Infrastructure
AQ
2017EMIS GROUP PLC : Ex-dividend day for interim dividend
FA
2017EMIS GROUP PLC : half-yearly earnings release
2017EMIS : Appointment of our new CEO
PU
2017EMIS : SystmOne and EMIS Web direct interoperability pilot now live
PU
2017EMIS : Updated statement on reported NHS cyber attack
PU
2017EMIS : Statement on reported NHS cyber attack
PU
2017EMIS GROUP PLC : Ex-dividend day for final dividend
FA
More news
News from SeekingAlpha
2015NOVO-NORDISK'S ORAL GLP-1 DIABETES T : An Update 
Financials ( GBP)
Sales 2018 167 M
EBIT 2018 33,5 M
Net income 2018 23,2 M
Finance 2018 16,6 M
Yield 2018 3,00%
P/E ratio 2018 19,25
P/E ratio 2019 18,49
EV / Sales 2018 3,30x
EV / Sales 2019 3,08x
Capitalization 566 M
Chart EMIS GROUP PLC
Duration : Period :
Emis Group Plc Technical Analysis Chart | EMIS | GB00B61D1Y04 | 4-Traders
Technical analysis trends EMIS GROUP PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 9,14  GBP
Spread / Average Target 2,1%
EPS Revisions
Managers
NameTitle
Andrew John Thorburn Chief Executive Officer & Executive Director
Michael Kevin O'Leary Non-Executive Chairman
Ian Taylor Group Chief Operating Officer
Peter John Southby Chief Financial Officer & Executive Director
Shaun O’Hanlon Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
EMIS GROUP PLC-11.47%752
VEEVA SYSTEMS INC49.86%11 844
ATHENAHEALTH, INC20.75%6 492
HEALTHEQUITY INC72.80%5 003
COTIVITI HOLDINGS INC37.19%4 107
ALLSCRIPTS HEALTHCARE SOLUTIONS INC-16.63%2 159